NCAM1 and acute myeloid leukemia: As reported in Table 1, in our cohort (n = 25), 21 patients showed LAIPs characterized by the partial expression of the aberrant lineage markers (CD7, CD4, CD56, and CD25) on AML cells at diagnosis.